Abiopharma

News list

FDA updates labeling for ACETAMINOPHEN AND IBUPROFEN

FDA Approval
Dec. 31, 2025, 13:45 UTC

Labeling changes approved for GRANULES. Active ingredient: ACETAMINOPHEN; IBUPROFEN. Decision date: 12/17/2025

Full text

Register to leave comments
There are no comments here yet...